Compare FIX & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FIX | NTRA |
|---|---|---|
| Founded | 1917 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Engineering & Construction | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.2B | 27.0B |
| IPO Year | 1997 | 2015 |
| Metric | FIX | NTRA |
|---|---|---|
| Price | $1,003.47 | $244.06 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 16 |
| Target Price | ★ $955.67 | $227.69 |
| AVG Volume (30 Days) | 540.8K | ★ 1.7M |
| Earning Date | 10-23-2025 | 11-06-2025 |
| Dividend Yield | ★ 0.24% | N/A |
| EPS Growth | ★ 80.49 | N/A |
| EPS | ★ 23.59 | N/A |
| Revenue | ★ $8,323,378,000.00 | $2,116,676,000.00 |
| Revenue This Year | $25.54 | $32.77 |
| Revenue Next Year | $15.00 | $16.51 |
| P/E Ratio | $42.46 | ★ N/A |
| Revenue Growth | 27.71 | ★ 38.17 |
| 52 Week Low | $276.44 | $125.38 |
| 52 Week High | $1,020.26 | $245.59 |
| Indicator | FIX | NTRA |
|---|---|---|
| Relative Strength Index (RSI) | 60.33 | 80.03 |
| Support Level | $910.05 | $233.67 |
| Resistance Level | $988.68 | $240.18 |
| Average True Range (ATR) | 44.24 | 7.39 |
| MACD | 3.04 | 0.68 |
| Stochastic Oscillator | 89.49 | 97.49 |
Comfort Systems USA Inc provides comprehensive mechanical contracting services, including heating, ventilation, & air conditioning, or HVAC; plumbing; piping & controls; construction; and other electrical components. Projects are mainly for commercial, industrial, & institutional buildings, & tend to be geared toward HVAC. Revenue is roughly split between installation services for newly constructed facilities & maintenance services for existing buildings. The company installs & repairs products and systems throughout the United States. It operates in two segments, Mechanical services & Electrical services, the majority is from the Mechanical services segment.
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.